Active	Status	Sponsor type	Region	Phase	Filter
2 Active 2 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Verheij, Theo JM
ImpresUWP3, NCT04077580 / 2018-002235-15: The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI	Completed	4	289	Europe	Methenamine Hippurate 1000 MG, Placebo tablets with identical size, shape and stamps	University of Oslo, Amsterdam UMC, location VUmc, UMC Utrecht, Göteborg University, Medical University of Lodz	Recurrent Urinary Tract Infection	06/23	06/23
EXPECT-1, NCT03968289: Study to Collect Information About Serious Infections Caused by E.Coli Bacteria	Not yet recruiting	N/A	6000	NA		UMC Utrecht, Janssen Research & Development, LLC, Innovative Medicines Initiative	E.Coli Infections	11/20	11/20
Baño, Jesus Rodriguez
No trials found

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Verheij, Theo JM
ImpresUWP3, NCT04077580 / 2018-002235-15: The Effect of Methenamine Hippurate to Reduce Antibiotic Prescribing in Elderly Women With Recurrent UTI	Completed	4	289	Europe	Methenamine Hippurate 1000 MG, Placebo tablets with identical size, shape and stamps	University of Oslo, Amsterdam UMC, location VUmc, UMC Utrecht, Göteborg University, Medical University of Lodz	Recurrent Urinary Tract Infection	06/23	06/23
EXPECT-1, NCT03968289: Study to Collect Information About Serious Infections Caused by E.Coli Bacteria	Not yet recruiting	N/A	6000	NA		UMC Utrecht, Janssen Research & Development, LLC, Innovative Medicines Initiative	E.Coli Infections	11/20	11/20
Baño, Jesus Rodriguez
No trials found